Showing results (1-10 of 638) with videos related to
Sort By:
Pageof 64
Leukemia|December 9, 1998
Acute promyelocytic leukemia: a curable diseaseF Lo Coco, C Nervi, G Avvisati, et al.Seminars in Hematology|February 15, 2001
Acute promyelocytic leukemia: clinical and morphologic features and prognostic factorsG Avvisati, F Lo Coco, F MandelliLa Ricerca in Clinica E in Laboratorio|April 1, 1984
ACTH 1-17 effects in acute myeloid leukemiaW Arcese, C Nervi, G Avvisati, et al.Leukemia|July 1, 1996
Improved rapid detection of the PML/RARalpha fusion gene in acute promyelocytic leukemiaD Diverio, R Riccioni, A Pistilli, et al.Blood|August 1, 1997
Autologous bone marrow transplantation for acute promyelocytic leukemia in second remission: prognostic relevance of pretransplant minimal residual disease assessment by reverse-transcription polymerase chain reaction of the PML/RAR alpha fusion geneG Meloni, D Diverio, M Vignetti, et al.Hematology/Oncology Clinics of North America|April 1, 1992
The role of interferon-alpha in the management of myelomatosisG Avvisati, F MandelliBlood|December 15, 1993
Absence of reverse transcription-polymerase chain reaction detectable residual disease in patients with acute promyelocytic leukemia in long-term remissionD Diverio, P P Pandolfi, A Biondi, et al.Haematologica|December 29, 1998
Therapy of acute myeloid leukemia: towards a patient-oriented, risk-adapted approachF Mandelli, M C Petti, F Lo CocoBlood|August 15, 1996
AIDA (all-trans retinoic acid + idarubicin) in newly diagnosed acute promyelocytic leukemia: a Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto (GIMEMA) pilot studyG Avvisati, F Lo Coco, D Diverio, et al.Cancer Research|July 1, 1992
Characterization of the PML-RAR alpha chimeric product of the acute promyelocytic leukemia-specific t(15;17) translocationC Nervi, E C Poindexter, F Grignani, et al.Pageof 64